Infos zu Corona - Aktuelle Informationen zu SARS-CoV-2 : Virus SARS-Cov-2 » Übertragung, Reproduktionszahl/ transmission, reproduction number

Virus SARS-Cov-2 » Übertragung, Reproduktionszahl/ transmission, reproduction number

Letzte Änderung: 10.12.2025 um 11:32 Uhr

Es gibt die Basisreproduktionszahl R0 und die Nettoreproduktionszahl R.

Die Basisreproduktionszahl sagt grundsätzlich aus, wie viele Personen durchschnittlich von einer einzigen infektiösen Person angesteckt werden - vorausgesetzt dass keiner gegenüber dem Erreger immun ist. Das RKI hatte für SARS-Cov-2 bei einer immunologischen naiven Bevölkerung (also ohne Impfschutz/ vorherige Erkrankung) eine R0 von 3,3 bis 3,8 ermittelt.

Dieser Wert kann sich durch Maßnahmen wie Abstand halten, Maske tragen, Quarantänemaßnahmen oder Immunität von Teilen der Bevölkerung (durch Impfungen oder vorhergehende Infektionen) ändern. Der aktuelle R-Wert gibt insofern an, wieviele Personen aktuell durchschnittlich von einer infektiösen Person angesteckt werden.

Bei der Berechnung wird auf Werte wie die Dauer der Inkubationszeit und die Dauer des durchschnittlichen Intervalls vom Beginn einer Erkrankung einer Ansteckung bis zum Beginn der Erkrankung des von der ersten Person angesteckten Falls zurückgegriffen.

Weiterführende Links zum Artikel

SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus (Hinzugefügt: 27.05.2022 um 07:50 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2792688
virus spreading dynamics model. (Hinzugefügt: 10.05.2022 um 08:42 Uhr)
https://covid-sim.info/
Monitoring SARS-CoV-2 in air and on surfaces and estimating infection risk in buildings and buses on a university campus (Hinzugefügt: 09.05.2022 um 08:58 Uhr)
https://www.nature.com/articles/s41370-022-00442-9
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 (Hinzugefügt: 11.04.2022 um 08:49 Uhr)
https://www.nature.com/articles/s41591-022-01816-0
Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain (Hinzugefügt: 08.04.2022 um 17:10 Uhr)
https://wwwnc.cdc.gov/eid/article/28/6/22-0158_article
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults (Hinzugefügt: 03.04.2022 um 17:58 Uhr)
https://www.nature.com/articles/s41591-022-01780-9
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees (Hinzugefügt: 16.03.2022 um 13:51 Uhr)
https://wwwnc.cdc.gov/eid/article/28/5/22-0197_article
Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea (Hinzugefügt: 12.03.2022 um 13:49 Uhr)
https://wwwnc.cdc.gov/eid/article/28/4/22-0153_article
Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron (Hinzugefügt: 06.03.2022 um 18:26 Uhr)
https://www.medrxiv.org/content/10.1101/2022.01.10.22269010v2
SARS-CoV-2 infiziert Menschen schneller als erwartet (Hinzugefügt: 14.02.2022 um 16:39 Uhr)
https://www.aerzteblatt.de/nachrichten/131496/SARS-CoV-2-infiziert-Menschen-schneller-als-erwartet
Preventing Fecal-Oral And Fecal-Aerosol Transmission Of Covid-19 (Hinzugefügt: 24.01.2022 um 19:50 Uhr)
https://www.forbes.com/sites/williamhaseltine/2021/03/22/preventing-fecal-oral-and-fecal-aerosol-transmission-of-covid-19/?sh=1f3134060d45
COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains (Hinzugefügt: 22.01.2022 um 13:25 Uhr)
https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab598/6505230
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building (Hinzugefügt: 22.01.2022 um 13:24 Uhr)
https://www.acpjournals.org/doi/10.7326/M20-0928
Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron (Hinzugefügt: 12.01.2022 um 09:36 Uhr)
https://www.medrxiv.org/content/10.1101/2022.01.10.22269010v1
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants (Hinzugefügt: 10.01.2022 um 12:20 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2116597
Active epidemiological investigation on SARS-CoV-2 infection caused by Omicron variant (Pango lineage B.1.1.529) in Japan: preliminary report on infectious period (Hinzugefügt: 10.01.2022 um 11:23 Uhr)
https://www.niid.go.jp/niid/en/2019-ncov-e/10884-covid19-66-en.html
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021 (Hinzugefügt: 28.12.2021 um 14:40 Uhr)
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.50.2101147
Coronavirus Can Persist for Months After Traversing Body (Hinzugefügt: 28.12.2021 um 14:25 Uhr)
https://www.bloomberg.com/news/articles/2021-12-26/coronavirus-can-persist-for-months-after-traversing-entire-body
SARS-CoV-2 spreads through cell-to-cell transmission (Hinzugefügt: 26.12.2021 um 10:44 Uhr)
https://www.pnas.org/content/119/1/e2111400119
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles (Hinzugefügt: 23.12.2021 um 20:02 Uhr)
https://www.medrxiv.org/content/10.1101/2021.12.20.21268048v1
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (Hinzugefügt: 23.12.2021 um 19:54 Uhr)
https://www.medrxiv.org/content/10.1101/2021.12.19.21268028v1
Severity of Omicron variant of concern and vaccine effectiveness against symptomatic disease: national cohort with nested test negative design study in Scotland (Hinzugefügt: 23.12.2021 um 19:45 Uhr)
https://www.pure.ed.ac.uk/ws/portalfiles/portal/245818096/Severity_of_Omicron_variant_of_concern_and_vaccine_effectiveness_against_symptomatic_disease.pdf
HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung (Hinzugefügt: 17.12.2021 um 13:52 Uhr)
https://www.med.hku.hk/en/news/press/20211215-omicron-sars-cov-2-infection?utm_medium=social&utm_source=twitter&utm_campaign=press_release
Estimating the increase in reproduction number associated with the Delta variant using local area dynamics in England (Hinzugefügt: 13.12.2021 um 11:20 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.30.21267056v1
Omicron strain spreads with the doubling time of 3.2—3.6 days in South Africa province of Gauteng that achieved herd immunity to Delta variant (Hinzugefügt: 13.12.2021 um 11:00 Uhr)
https://www.medrxiv.org/content/10.1101/2021.12.08.21267494v1
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons (Hinzugefügt: 06.12.2021 um 13:51 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2102507
Generation and transmission of inter-lineage recombinants in the SARS-CoV-2 pandemic (Hinzugefügt: 03.12.2021 um 17:39 Uhr)
https://www.medrxiv.org/content/10.1101/2021.06.18.21258689v1
SARS-CoV-2 Delta variant saliva viral load is 15-fold higher than wild-type strains (Hinzugefügt: 02.12.2021 um 06:57 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.29.21266980v1
'Patience is crucial': Why we won't know for weeks how dangerous Omicron is (Hinzugefügt: 28.11.2021 um 15:01 Uhr)
https://www.science.org/content/article/patience-crucial-why-we-won-t-know-weeks-how-dangerous-omicron
Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology (Hinzugefügt: 19.11.2021 um 15:12 Uhr)
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8283343/
NIH scientists identify mechanism that may influence infectivity of SARS-CoV-2 variants (Hinzugefügt: 09.11.2021 um 16:27 Uhr)
https://www.nih.gov/news-events/news-releases/nih-scientists-identify-mechanism-may-influence-infectivity-sars-cov-2-variants
SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity (Hinzugefügt: 09.11.2021 um 15:36 Uhr)
https://www.biorxiv.org/content/10.1101/2021.11.05.467523v1
Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells (Hinzugefügt: 04.11.2021 um 09:06 Uhr)
https://www.mdpi.com/1999-4915/13/11/2193/htm
Was die Delta-Variante so ansteckend macht (Hinzugefügt: 29.10.2021 um 13:33 Uhr)
https://www.aerzteblatt.de/nachrichten/128503/Was-die-Delta-Variante-so-ansteckend-macht
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study (Hinzugefügt: 29.10.2021 um 11:48 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00648-4/fulltext
Dose-dependent COVID-19 symptoms (Hinzugefügt: 18.10.2021 um 10:33 Uhr)
https://www.nature.com/articles/s41579-021-00634-4?utm_source=nrmicro_etoc&utm_medium=email&utm_campaign=toc_41579_19_11&utm_content=20211011&sap-outbound-id=D381D0B49EE96C4BA4C624ACBF4346AE9FCE3050
Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate (Hinzugefügt: 15.09.2021 um 14:50 Uhr)
https://www.bmj.com/content/374/bmj.n2074
The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus (Hinzugefügt: 24.08.2021 um 17:09 Uhr)
https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab124/6346388
Estimating infectiousness throughout SARS-CoV-2 infection course (Hinzugefügt: 24.08.2021 um 16:43 Uhr)
https://science.sciencemag.org/content/373/6551/eabi5273.full
Delta’s rise is fuelled by rampant spread from people who feel fine (Hinzugefügt: 24.08.2021 um 16:30 Uhr)
https://www.nature.com/articles/d41586-021-02259-2?utm_source=twt_nat&utm_medium=social&utm_campaign=nature
The mutation that helps Delta spread like wildfire (Hinzugefügt: 24.08.2021 um 16:16 Uhr)
https://www.nature.com/articles/d41586-021-02275-2?utm_source=twt_nat&utm_medium=social&utm_campaign=nature
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals (Hinzugefügt: 24.08.2021 um 16:15 Uhr)
https://www.medrxiv.org/content/10.1101/2021.08.15.21262077v1
How do vaccinated people spread Delta? What the science says (Hinzugefügt: 14.08.2021 um 09:06 Uhr)
https://www.nature.com/articles/d41586-021-02187-1
Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing (Hinzugefügt: 08.08.2021 um 07:08 Uhr)
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab691/6343417
SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance (Hinzugefügt: 07.08.2021 um 15:59 Uhr)
https://www.biorxiv.org/content/10.1101/2021.07.28.454085v1
Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic (Hinzugefügt: 06.08.2021 um 11:36 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00406-0/fulltext
Infections caused by the Delta variant (B.1.617.2) of SARS-CoV-2 are associated with increased viral loads compared to infections with the Alpha variant (B.1.1.7) or non-Variants of Concern. (Hinzugefügt: 06.08.2021 um 11:31 Uhr)
https://www.researchsquare.com/article/rs-777577/v1
How the coronavirus infects cells — and why Delta is so dangerous (Hinzugefügt: 03.08.2021 um 10:29 Uhr)
https://www.nature.com/articles/d41586-021-02039-y
US-Gesundheitsbehörde: Delta-Variante so ansteckend wie Windpocken – trotz Impfung (Hinzugefügt: 03.08.2021 um 09:43 Uhr)
https://www.aerzteblatt.de/nachrichten/126034/US-Gesundheitsbehoerde-Delta-Variante-so-ansteckend-wie-Windpocken-trotz-Impfung
Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant (Hinzugefügt: 03.08.2021 um 09:03 Uhr)
https://www.medrxiv.org/content/10.1101/2021.07.31.21261387v1
Networks of SARS-CoV-2 transmission (Hinzugefügt: 09.07.2021 um 19:15 Uhr)
https://science.sciencemag.org/content/373/6551/162
Australia Finds Delta Covid-19 Variant Transmits In Less Than 10 Seconds (Hinzugefügt: 01.07.2021 um 08:46 Uhr)
https://codeblue.galencentre.org/2021/06/25/australia-finds-delta-covid-19-variant-transmits-in-less-than-10-seconds/
SARS-CoV-2: Warum Alpha ansteckender ist und Beta eher der Immunantwort entgeht (Hinzugefügt: 30.06.2021 um 15:06 Uhr)
https://www.aerzteblatt.de/nachrichten/125074/SARS-CoV-2-Warum-Alpha-ansteckender-ist-und-Beta-eher-der-Immunantwort-entgeht
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study (Hinzugefügt: 23.06.2021 um 18:04 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00290-5/fulltext
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study (Hinzugefügt: 23.06.2021 um 18:04 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00318-2/fulltext
REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant (Hinzugefügt: 22.06.2021 um 07:19 Uhr)
https://www.medrxiv.org/content/10.1101/2021.06.17.21259103v1
Has SARS-CoV-2 reached peak fitness? (Hinzugefügt: 22.06.2021 um 07:18 Uhr)
https://www.nature.com/articles/s41591-021-01421-7
Uncovering transmission patterns of COVID-19 outbreaks: A region-wide comprehensive retrospective study in Hong Kong (Hinzugefügt: 20.06.2021 um 17:33 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00209-1/fulltext
Study: Kids with COVID-19 may be as contagious as adults (Hinzugefügt: 13.06.2021 um 16:32 Uhr)
https://www.upi.com/Health_News/2021/06/11/COVID-19-children-adults-symptoms-study/5171623417738/?ur3=1
SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization (Hinzugefügt: 06.06.2021 um 14:50 Uhr)
https://www.biorxiv.org/content/10.1101/2021.06.01.446516v1
Those vaccinated and those cured of the covid can transmit the coronavirus even if they do not have symptoms (Hinzugefügt: 27.05.2021 um 15:51 Uhr)
https://elpais.com/ciencia/2021-05-26/varios-estudios-advierten-de-que-personas-vacunadas-o-que-han-pasado-la-covid-pueden-infectarse-sin-notarlo.html
Estimating infectiousness throughout SARS-CoV-2 infection course (Hinzugefügt: 26.05.2021 um 08:55 Uhr)
https://science.sciencemag.org/content/early/2021/05/24/science.abi5273.full
Drosten-Studie: Kinder ansteckend wie Erwachsene (Hinzugefügt: 26.05.2021 um 08:54 Uhr)
https://www.n-tv.de/wissen/Drosten-Studie-Kinder-ansteckend-wie-Erwachsene-article22575973.html
Brazilian coronavirus variant likely to be more transmissible and able to evade immunity (Hinzugefügt: 04.05.2021 um 05:29 Uhr)
https://healthsciences.ku.dk/newsfaculty-news/2021/04/brazilian-coronavirus-variant-likely-to-be-more-transmissible-and-able-to-evade-immunity/
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets (Hinzugefügt: 30.04.2021 um 06:05 Uhr)
https://www.nature.com/articles/s41564-021-00908-w
The incubation period of COVID-19: A meta-analysis (Hinzugefügt: 30.04.2021 um 06:05 Uhr)
https://pubmed.ncbi.nlm.nih.gov/33548553/
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant (Hinzugefügt: 22.04.2021 um 12:23 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(21)00505-5
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells (Hinzugefügt: 21.04.2021 um 05:57 Uhr)
https://www.cell.com/iscience/fulltext/S2589-0042(21)00396-5
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant (Hinzugefügt: 21.04.2021 um 05:55 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(21)00505-5
An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity (Hinzugefügt: 18.04.2021 um 17:01 Uhr)
https://www.biorxiv.org/content/10.1101/2021.04.02.438288v1
B.1.1.7 variant more transmissible but does not increase disease severity, two new studies suggest (Hinzugefügt: 13.04.2021 um 11:09 Uhr)
https://edition.cnn.com/2021/04/12/health/b117-variant-covid-19-lancet-studies/index.html
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study (Hinzugefügt: 13.04.2021 um 11:02 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00170-5/fulltext
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (Hinzugefügt: 13.04.2021 um 10:57 Uhr)
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00055-4/fulltext
Newly Discovered Virus-Cell Interaction May Explain COVID-19’s High Infection Rate (Hinzugefügt: 12.04.2021 um 18:10 Uhr)
https://scitechdaily.com/newly-discovered-virus-cell-interaction-may-explain-covid-19s-high-infection-rate/
COVID-19 antibodies appear to ward off B117 better than B1351 (Hinzugefügt: 30.03.2021 um 08:30 Uhr)
https://www.cidrap.umn.edu/news-perspective/2021/03/covid-19-antibodies-appear-ward-b117-better-b1351
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (Hinzugefügt: 28.03.2021 um 08:43 Uhr)
https://www.nature.com/articles/s41591-021-01318-5.epdf?sharing_token=Ul7FPZJiHkIMYXpC3mkUhtRgN0jAjWel9jnR3ZoTv0Nwj5GGz7SFDx_u5BQFSfntlska9-5mwV4-VoifSb2J2qrOvgzbH2-lrs3BkDxSpriEguPTnsgcaBpUt96SaLD__xxISov_PjHw-kMdjKUXBPKwBYhr4wdYUUkJY9FzIhQ%3D
Prost-Covid! (Hinzugefügt: 26.03.2021 um 20:50 Uhr)
https://www.doccheck.com/de/detail/articles/32375-prost-covid
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England (Hinzugefügt: 25.03.2021 um 20:21 Uhr)
https://www.nature.com/articles/s41586-021-03470-x
Scientists find evidence that novel coronavirus infects the mouth’s cells (Hinzugefügt: 25.03.2021 um 20:18 Uhr)
https://www.nih.gov/news-events/news-releases/scientists-find-evidence-novel-coronavirus-infects-mouths-cells
Sturdier Coronavirus Spike Protein Explains Faster Spread of COVID Variants From UK, South Africa, and Brazil (Hinzugefügt: 21.03.2021 um 06:53 Uhr)
https://scitechdaily.com/sturdier-coronavirus-spike-protein-explains-faster-spread-of-covid-variants-from-uk-south-africa-and-brazil/
Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA Load Status and Antibody Distribution Among Patients and Asymptomatic Carriers in Central China (Hinzugefügt: 20.03.2021 um 18:40 Uhr)
https://www.frontiersin.org/articles/10.3389/fcimb.2021.559447/full
Structural impact on SARS-CoV-2 spike protein by D614G substitution (Hinzugefügt: 17.03.2021 um 01:56 Uhr)
https://science.sciencemag.org/content/early/2021/03/16/science.abf2303.full
B117 deadlier than other COVID-19 strains, more data affirm (Hinzugefügt: 16.03.2021 um 08:01 Uhr)
https://www.cidrap.umn.edu/news-perspective/2021/03/b117-deadlier-other-covid-19-strains-more-data-affirm
Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without (Hinzugefügt: 15.03.2021 um 19:27 Uhr)
https://www.sciencedirect.com/science/article/pii/S2589004221001383
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study (Hinzugefügt: 10.03.2021 um 20:16 Uhr)
https://www.bmj.com/content/372/bmj.n579
UK COVID-19 variant has significantly higher death rate, study finds (Hinzugefügt: 10.03.2021 um 20:14 Uhr)
https://www.reuters.com/article/us-health-coronavirus-variant-britain-idUSKBN2B213E
SARS-CoV-2 within-host diversity and transmission View ORCID Profile (Hinzugefügt: 10.03.2021 um 08:01 Uhr)
https://science.sciencemag.org/content/early/2021/03/09/science.abg0821.full
SARS-CoV-2: Rasche Ausbreitung in Manaus deutet auf hohe Aggressivität der Linie P.1 hin (Hinzugefügt: 06.03.2021 um 08:05 Uhr)
https://www.aerzteblatt.de/nachrichten/121804/SARS-CoV-2-Rasche-Ausbreitung-in-Manaus-deutet-auf-hohe-Aggressivitaet-der-Linie-P-1-hin
Increased Risk of Hospitalisation Associated with Infection with SARS-CoV-2 Lineage B.1.1.7 in DenmarkIncreased Risk of Hospitalisation Associated with Infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark (Hinzugefügt: 05.03.2021 um 07:18 Uhr)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3792894
Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil (Hinzugefügt: 04.03.2021 um 08:10 Uhr)
https://www.medrxiv.org/content/10.1101/2021.02.26.21252554v1
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England (Hinzugefügt: 04.03.2021 um 07:59 Uhr)
https://science.sciencemag.org/content/early/2021/03/03/science.abg3055.full
Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics (Hinzugefügt: 03.03.2021 um 08:35 Uhr)
https://www.nature.com/articles/s41591-020-01227-z
All our recent progress with Covid-19 could be wiped out by variants, CDC director says. 'Please stay strong' (Hinzugefügt: 02.03.2021 um 06:57 Uhr)
https://edition.cnn.com/2021/03/01/health/us-coronavirus-monday/index.html
California coronavirus strain may be more infectious—and lethal (Hinzugefügt: 01.03.2021 um 08:40 Uhr)
https://www.sciencemag.org/news/2021/02/coronavirus-strain-first-identified-california-may-be-more-infectious-and-cause-more
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 (Hinzugefügt: 24.02.2021 um 08:50 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2027040
Size and duration of COVID-19 clusters go along with a high SARS-CoV-2 viral load : a spatio-temporal investigation in Vaud state, Switzerland (Hinzugefügt: 20.02.2021 um 12:26 Uhr)
https://www.medrxiv.org/content/10.1101/2021.02.16.21251641v1
Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 (Hinzugefügt: 17.02.2021 um 18:26 Uhr)
https://dash.harvard.edu/handle/1/37366884
The Rὺm Model technical annex (Hinzugefügt: 15.02.2021 um 08:54 Uhr)
https://www.gov.uk/government/publications/the-r-m-model-technical-annex
NERVTAG: Update note on B.1.1.7 severity, 11 February 2021 (Hinzugefügt: 15.02.2021 um 08:50 Uhr)
https://www.gov.uk/government/publications/nervtag-update-note-on-b117-severity-11-february-2021
Exhaled aerosol increases with COVID-19 infection, age, and obesity (Hinzugefügt: 13.02.2021 um 13:30 Uhr)
https://www.pnas.org/content/118/8/e2021830118
calculated Rt (Hinzugefügt: 11.02.2021 um 21:32 Uhr)
https://rt.live/
tägliche Vorhersagen des R-Werts für deutsche Bundesländer (Hinzugefügt: 11.02.2021 um 21:31 Uhr)
https://rtlive.de/
Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01 (Hinzugefügt: 11.02.2021 um 21:30 Uhr)
https://www.medrxiv.org/content/10.1101/2021.02.01.21250959v2
SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions (Hinzugefügt: 10.02.2021 um 09:42 Uhr)
https://www.sciencedirect.com/science/article/pii/S1567134821000575
Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England (Hinzugefügt: 07.02.2021 um 10:11 Uhr)
https://cmmid.github.io/topics/covid19/uk-novel-variant.html
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study (Hinzugefügt: 03.02.2021 um 07:28 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30985-3/fulltext
Estimating the Effective Reproduction Number of COVID-19 by Country (Hinzugefügt: 31.01.2021 um 10:18 Uhr)
https://lrossouw.github.io/covid-19/estimating_r_world.html
The coronavirus proofreading exoribonuclease mediates extensive viral recombination (Hinzugefügt: 30.01.2021 um 11:29 Uhr)
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009226
Dishonesty during a pandemic: The concealment of COVID-19 information (Hinzugefügt: 30.01.2021 um 11:28 Uhr)
https://journals.sagepub.com/doi/full/10.1177/1359105320951603
SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor (Hinzugefügt: 30.01.2021 um 11:16 Uhr)
https://www.biorxiv.org/content/10.1101/2021.01.06.425392v3
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis (Hinzugefügt: 27.01.2021 um 09:34 Uhr)
https://www.nature.com/articles/s41586-021-03237-4?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature
SARS-CoV-2 recruits a haem metabolite to evade antibody immunity (Hinzugefügt: 27.01.2021 um 09:34 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.21.21249203v1
An observational study of SARS-CoV-2 infectivity by viral load and 2 demographic factors and the utility lateral flow devices to prevent 3 transmission (Hinzugefügt: 23.01.2021 um 09:33 Uhr)
http://modmedmicro.nsms.ox.ac.uk/wp-content/uploads/2021/01/infectivity_manuscript_20210119_merged.pdf
Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update (Hinzugefügt: 22.01.2021 um 21:47 Uhr)
https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-spread-new-variants-concern-eueea-first-update
SARS-CoV-2: Laborexperimente deuten auf verminderte Schutzwirkung gegen neue Varianten hin (Hinzugefügt: 21.01.2021 um 19:23 Uhr)
https://www.aerzteblatt.de/nachrichten/120379/SARS-CoV-2-Laborexperimente-deuten-auf-verminderte-Schutzwirkung-gegen-neue-Varianten-hin
Estimates of severity and transmissibility of novel South Africa SARS-CoV-2 variant 501Y.V2 (Hinzugefügt: 20.01.2021 um 20:33 Uhr)
https://cmmid.github.io/topics/covid19/sa-novel-variant.html
Increased infections, but not viral burden, with a new SARS-CoV-2 variant (Hinzugefügt: 17.01.2021 um 07:43 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.13.21249721v1
Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus (SARS-CoV-2) (Hinzugefügt: 14.01.2021 um 08:51 Uhr)
https://www.journalofhospitalinfection.com/article/S0195-6701(21)00007-4/fulltext
Wie SARS-CoV-2 Großbritannien eroberte (Hinzugefügt: 12.01.2021 um 08:03 Uhr)
https://www.aerzteblatt.de/nachrichten/120051/Wie-SARS-CoV-2-Grossbritannien-eroberte
Study: Symptom-free infected people cause at least half of COVID-19 spread (Hinzugefügt: 10.01.2021 um 09:16 Uhr)
https://www.upi.com/Health_News/2021/01/07/Study-Symptom-free-infected-people-cause-at-least-half-of-COVID-19-spread/1781610029957/
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK (Hinzugefügt: 09.01.2021 um 10:17 Uhr)
https://science.sciencemag.org/content/early/2021/01/07/science.abf2946.full
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms (Hinzugefügt: 08.01.2021 um 09:42 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2774707
Viral mutations may cause another ‘very, very bad’ COVID-19 wave, scientists warn (Hinzugefügt: 06.01.2021 um 08:31 Uhr)
https://www.sciencemag.org/news/2021/01/viral-mutations-may-cause-another-very-very-bad-covid-19-wave-scientists-warn
Cold sensitivity of the SARS-CoV-2 spike ectodomain (Hinzugefügt: 06.01.2021 um 08:28 Uhr)
https://www.nature.com/articles/s41594-020-00547-5
Structure-function investigation of a new VUI-202012/01 SARS-CoV-2 variant (Hinzugefügt: 05.01.2021 um 08:16 Uhr)
https://www.biorxiv.org/content/10.1101/2021.01.01.425028v1
New variant of SARS-CoV-2 in UK causes surge of COVID-19 (Hinzugefügt: 05.01.2021 um 08:13 Uhr)
https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S2213260021000059.pdf
Infectivity of asymptomatic versus symptomatic COVID-19 (Hinzugefügt: 04.01.2021 um 11:01 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32651-9/fulltext
The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation (Hinzugefügt: 03.01.2021 um 10:27 Uhr)
https://www.biorxiv.org/content/10.1101/2020.12.29.424708v1
Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients (Hinzugefügt: 03.01.2021 um 10:22 Uhr)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0243597
Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England (Hinzugefügt: 02.01.2021 um 09:09 Uhr)
https://cmmid.github.io/topics/covid19/reports/uk-novel-variant/2020_12_23_Transmissibility_and_severity_of_VOC_202012_01_in_England.pdf
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data (Hinzugefügt: 01.01.2021 um 19:23 Uhr)
https://virological.org/t/transmission-of-sars-cov-2-lineage-b-1-1-7-in-england-insights-from-linking-epidemiological-and-genetic-data/576
S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-QPCR (Hinzugefügt: 31.12.2020 um 11:37 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.24.20248834v1
Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas (Hinzugefügt: 17.12.2020 um 18:29 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.15.20248273v1
Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients (Hinzugefügt: 11.12.2020 um 08:03 Uhr)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0243597
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 (Hinzugefügt: 10.12.2020 um 09:38 Uhr)
https://stm.sciencemag.org/content/12/573/eabe2555.full
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong (Hinzugefügt: 28.11.2020 um 10:00 Uhr)
https://www.nature.com/articles/s41591-020-1092-0
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong (Hinzugefügt: 28.11.2020 um 10:00 Uhr)
https://www.nature.com/articles/s41591-020-1092-0
The K factor: why it matters where we are infected with the coronavirus (Hinzugefügt: 28.11.2020 um 09:58 Uhr)
https://english.elpais.com/society/2020-10-30/the-k-factor-why-it-matters-where-we-are-infected-with-the-coronavirus.html
Does temperature affect COVID-19 transmission? (Hinzugefügt: 27.11.2020 um 10:51 Uhr)
https://www.frontiersin.org/articles/10.3389/fpubh.2020.554964/abstract
Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 (Hinzugefügt: 25.11.2020 um 09:21 Uhr)
https://science.sciencemag.org/content/early/2020/11/23/science.abe2424.full
RKI Nowcasting und R-Schätzung (Hinzugefügt: 22.11.2020 um 12:29 Uhr)
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/Nowcasting.html;jsessionid=247E53150579385F1A47BDE230FF28EF.internet092
Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks (Hinzugefügt: 11.11.2020 um 08:02 Uhr)
https://wellcomeopenresearch.org/articles/5-239
R0 Wert (Hinzugefügt: 10.11.2020 um 14:39 Uhr)
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html#doc13776792bodyText3
R Wert (Hinzugefügt: 10.11.2020 um 14:39 Uhr)
https://de.wikipedia.org/wiki/COVID-19-Pandemie_in_Deutschland#Reproduktionszahl
R-Value Calculator (Hinzugefügt: 06.11.2020 um 18:01 Uhr)
https://covid-sim.info/r-calcs/2020-10-23
superspreading (Hinzugefügt: 06.11.2020 um 15:01 Uhr)
https://www.pnas.org/content/early/2020/10/30/2018490117

Mehr zum Thema "Virus SARS-Cov-2"

Übertragung, Reproduktionszahl/ transmission, reproduction number 6. November 2020 16:01 Erkrankung COVID-19 25. Oktober 2020 18:44 allgemeines zum Virus SARS-CoV-2 25. Oktober 2020 18:40

Weitere Themen

SARS-CoV-2 Pandemie Virus SARS-Cov-2 Masken/ masks Luftreiniger Risikoreduktion in D in Vergangenheit verfügbare Impfstoffe gegen "alte" Virusvarianten Impfung LP.8.1/JN.1: Herbst 2025 in D verfügbare Impfstoffe PrEP für Risikopatienten Tests Erkrankung - Symptome Covid-19 Risikopatienten Frühtherapie (erste Erkrankungstage) weitere Behandlung monoklonale Antikörper 14y evtl. wirksame Behandlung grds. nicht empfohlene Behandlung Long- Covid/ Post- Covid Rechtliches/ legal information Meine persönliche Vorgehensweise/ My personal approach 18 NICHT SARS-CoV-2 Übertragung Übertragungssituationen 2c Reisen/ travelling 3 NPIs 7y Immunität nach Infektion/ immunity after infection 0 alt Corona- Pandemie 10 Was tun wenn infiziert?/ To do when tested positive? 7a allg. zu Impfungen/ vaccinations

« Zurück zur Übersicht